Cargando…
Pharmacokinetics of DA-6886, A New 5-HT(4) Receptor Agonist, in Rats
DA-6886 is a novel serotonin (5-hydroxytrypamine [5-HT]) receptor 4 agonist for the potential treatment of constipation-predominant irritable bowel syndrome. The purpose of this study was to validate the quantitative assay of DA-6886 in rat plasma and to evaluate the pharmacokinetics and tissue dist...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024849/ https://www.ncbi.nlm.nih.gov/pubmed/35456538 http://dx.doi.org/10.3390/pharmaceutics14040702 |